NTLA Intellia Therapeutics Inc.

$26.135 +0.71%

761,828 Shares Traded
866,143 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $753.45 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-18.87%
If Intiated One Month Ago, Shorts Have Realized a Return of:-18.05%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.12%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 11.79%
Short Interest4.07 million
Float34.56 million
Short Ratio4.02
Market Cap$922.71 million
Market Maker ActivityDaily Short Volume


Sangamo Therapeutics: Great Start To 2018 - $3 Billion KITE Announcement (SeekingAlpha)
U.S. Biotech/Pharma Sector Daily Observations Letter: February 15, 2018 (SeekingAlpha)
Key events next week - healthcare (SeekingAlpha)
Mergers And Acquisitions: Is There A Pending Catalyst For Crispr Therapeutics? (SeekingAlpha)
CRISPR/Cas9 gene editors in the green on Gilead deal interest (SeekingAlpha)
BioSci Rounds Report For Feb. 2, 2018 (SeekingAlpha)
Solid Biosciences slips (SeekingAlpha)
Ionis Pharmaceuticals Is Poised To Disrupt Biotech (SeekingAlpha)
Midday Gainers / Losers (SeekingAlpha)
CRISPR/Cas9 gene-editing firms under pressure on paper questioning potential efficacy of cutting element (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 77.1%

Earnings Stats

PE Ratio -16.39
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $19.95
50 Day Moving Average $21.91
52 Week High $33.34
52 Week Low $11.15

Data provided for free by IEX. Questions? Read the FAQ